Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy Evaluation of DOTAREM® in Magnetic Resonance Imaging (MRI) in Patients With Central Nervous System (CNS) Lesions.

NCT01211873 is registered in ClinicalTrials.gov with Guerbet as lead sponsor.

NCT NCT01211873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01211873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy Evaluation of DOTAREM® in Magnetic Resonance Imaging (MRI) in Patients With Central Nervous System (CNS) Lesions.
Lead sponsor
Guerbet
Phase
Phase 3
Overall status
Completed
Start date
September 30, 2010
Completion date
November 30, 2011
Enrollment
416 (actual)
Sites
52

Conditions

As the registry lists them; a condition with its own page is linked.

central nervous system diseases, diagnostic self evaluation